- Investing Ideas
- /
- Swiss Undervalued Stocks Based On Cash Flows
Swiss Undervalued Stocks Based On Cash Flows
Results
18
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
18 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
COTN | CHF 341.00 | 6.9% | 53.9% | CHF 2.7b | CHF 391.33 | PE151.4x | E48.3% | 0.3% | Tech | ||
SQN | CHF 304.40 | 9.3% | 68.5% | CHF 4.5b | CHF 298.60 | PE17.7x | E12.9% | 1.4% | Diversified Financials | ||
EMMN | CHF 879.00 | -2.7% | -4.9% | CHF 4.7b | CHF 1,000.25 | PE24.4x | E15.3% | 1.8% | Food, Beverage & Tobacco | ||
GURN | CHF 41.00 | -4.3% | -50.8% | CHF 191.7m | CHF 75.00 | PE25.7x | E31.1% | 0.9% | Materials | ||
GF | CHF 64.25 | 3.3% | 14.3% | CHF 5.3b | CHF 75.50 | PE25.2x | E23.0% | 2.0% | Capital Goods | ||
ARBN | CHF 12.46 | 3.0% | 37.1% | CHF 864.1m | CHF 14.40 | PS1.7x | E100.1% | 0% | Capital Goods | ||
CLN | CHF 12.87 | 5.5% | -4.9% | CHF 4.2b | CHF 16.01 | PE35.9x | E30.4% | 3.3% | Materials | ||
SGSN | CHF 93.18 | 1.5% | 15.6% | CHF 17.6b | CHF 92.02 | PE32.2x | E12.3% | 3.4% | Commercial Services | ||
LMN | CHF 19.80 | 11.2% | -12.6% | CHF 211.5m | CHF 25.98 | PE23.1x | E30.0% | 2.9% | Consumer Services | ||
DAE | CHF 172.20 | -2.9% | 0.6% | CHF 2.9b | CHF 182.00 | PE39.9x | E23.8% | 1.9% | Capital Goods | ||
LEHN | CHF 1,256.00 | 9.4% | -35.8% | CHF 1.4b | CHF 1,609.50 | PE28.9x | E18.4% | 4.0% | Tech | ||
TEMN | CHF 59.55 | 6.8% | -12.8% | CHF 4.3b | CHF 65.14 | PE36.9x | E14.3% | 1.9% | Software | ||
VACN | CHF 429.20 | 5.2% | 24.6% | CHF 12.9b | CHF 485.00 | PE64.3x | E22.5% | 1.5% | Capital Goods | ||
UBXN | CHF 79.20 | 2.7% | 5.0% | CHF 583.4m | CHF 80.00 | PS1.6x | E108.3% | 1.3% | Semiconductors | ||
SWON | CHF 17.10 | 0.9% | -7.3% | CHF 2.6b | CHF 17.98 | PE123.1x | E35.0% | 2.1% | Tech | ||
SKAN | CHF 79.40 | 2.5% | 2.5% | CHF 1.8b | CHF 97.50 | PE67.8x | E20.6% | 0.4% | Pharmaceuticals & Biotech | ||
ZEHN | CHF 53.70 | 3.9% | -6.9% | CHF 585.9m | CHF 66.55 | PE26.9x | E32.6% | 2.3% | Capital Goods | ||
STMN | CHF 124.80 | 11.9% | -4.7% | CHF 19.9b | CHF 134.83 | PE64.8x | E21.0% | 0.7% | Healthcare |
Page 1 of 1